276 related articles for article (PubMed ID: 27150371)
1. Pyrimidine-fused Derivatives: Synthetic Strategies and Medicinal Attributes.
Joshi G; Nayyar H; Alex JM; Vishwakarma GS; Mittal S; Kumar R
Curr Top Med Chem; 2016; 16(28):3175-3210. PubMed ID: 27150371
[TBL] [Abstract][Full Text] [Related]
2. An Overview of the Synthetic Route to the Marketed Formulations of Pyrimidine: A Review.
Kumar A; Siwach A; Verma P
Mini Rev Med Chem; 2022; 22(6):884-903. PubMed ID: 34629043
[TBL] [Abstract][Full Text] [Related]
3. Thieno[2,3-d]pyrimidine as a promising scaffold in medicinal chemistry: Recent advances.
Ali EMH; Abdel-Maksoud MS; Oh CH
Bioorg Med Chem; 2019 Apr; 27(7):1159-1194. PubMed ID: 30826188
[TBL] [Abstract][Full Text] [Related]
4. Pyrimidine: An elite heterocyclic leitmotif in drug discovery-synthesis and biological activity.
Nadar S; Khan T
Chem Biol Drug Des; 2022 Dec; 100(6):818-842. PubMed ID: 34914188
[TBL] [Abstract][Full Text] [Related]
5. Pyrazoloquinazolines: Synthetic strategies and bioactivities.
Garg M; Chauhan M; Singh PK; Alex JM; Kumar R
Eur J Med Chem; 2015 Jun; 97():444-61. PubMed ID: 25438709
[TBL] [Abstract][Full Text] [Related]
6. The Chemistry and Bio-Medicinal Significance of Pyrimidines & Condensed Pyrimidines.
Jain KS; Arya N; Inamdar NN; Auti PB; Unawane SA; Puranik HH; Sanap MS; Inamke AD; Mahale VJ; Prajapati CS; Shishoo CJ
Curr Top Med Chem; 2016; 16(28):3133-3174. PubMed ID: 27291985
[TBL] [Abstract][Full Text] [Related]
7. Fused and Substituted Pyrimidine Derivatives as Profound Anti-Cancer Agents.
Abbas N; Matada GSP; Dhiwar PS; Patel S; Devasahayam G
Anticancer Agents Med Chem; 2021; 21(7):861-893. PubMed ID: 32698738
[TBL] [Abstract][Full Text] [Related]
8. Pyrrolopyrimidines: An update on recent advancements in their medicinal attributes.
Pathania S; Rawal RK
Eur J Med Chem; 2018 Sep; 157():503-526. PubMed ID: 30114661
[TBL] [Abstract][Full Text] [Related]
9. An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold.
Cherukupalli S; Karpoormath R; Chandrasekaran B; Hampannavar GA; Thapliyal N; Palakollu VN
Eur J Med Chem; 2017 Jan; 126():298-352. PubMed ID: 27894044
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer pyrimidines in diverse scaffolds: a review of patent literature.
Kaur R; Kaur P; Sharma S; Singh G; Mehndiratta S; Bedi PM; Nepali K
Recent Pat Anticancer Drug Discov; 2015; 10(1):23-71. PubMed ID: 25230072
[TBL] [Abstract][Full Text] [Related]
11. Synthetic and Biological Attributes of Pyrimidine Derivatives: A Recent Update.
Devi M; Jaiswal S; Jain S; Kaur N; Dwivedi J
Curr Org Synth; 2021; 18(8):790-825. PubMed ID: 34886770
[TBL] [Abstract][Full Text] [Related]
12. An appraisal on synthetic and pharmaceutical perspectives of pyrazolo[4,3-d]pyrimidine scaffold.
Cherukupalli S; Hampannavar GA; Chinnam S; Chandrasekaran B; Sayyad N; Kayamba F; Reddy Aleti R; Karpoormath R
Bioorg Med Chem; 2018 Jan; 26(2):309-339. PubMed ID: 29273417
[TBL] [Abstract][Full Text] [Related]
13. Five-membered heteroaromatic ring fused-pyrimidine derivatives: design, synthesis, and hedgehog signaling pathway inhibition study.
Zhang L; Xin M; Shen H; Wen J; Tang F; Tu C; Zhao X; Wei P
Bioorg Med Chem Lett; 2014 Aug; 24(15):3486-92. PubMed ID: 24923765
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive review in current developments of imidazole-based medicinal chemistry.
Zhang L; Peng XM; Damu GL; Geng RX; Zhou CH
Med Res Rev; 2014 Mar; 34(2):340-437. PubMed ID: 23740514
[TBL] [Abstract][Full Text] [Related]
15. Structural Activity Relationship based Medicinal Perspectives of Pyrimidine Derivatives as Anti-Alzheimer's Agents: A Comprehensive Review.
Das S; Akbar S; Ahmed B; Dewangan RP; Iqubal A; Pottoo FH; Joseph A
CNS Neurol Disord Drug Targets; 2022; 21(10):926-939. PubMed ID: 34348636
[TBL] [Abstract][Full Text] [Related]
16. Pyrimidine-fused Dinitrogenous Penta-heterocycles as a Privileged Scaffold for Anti-Cancer Drug Discovery.
Li W; Zhang J; Wang M; Dong R; Zhou X; Zheng X; Sun L
Curr Top Med Chem; 2022 Mar; 22(4):284-304. PubMed ID: 35021973
[TBL] [Abstract][Full Text] [Related]
17. Bridgehead Nitrogen Thiazolo[3,2-a]pyrimidine: A Privileged Structural Framework in Drug Discovery.
Keshari AK; Singh AK; Saha S
Mini Rev Med Chem; 2017; 17(15):1488-1499. PubMed ID: 28215139
[TBL] [Abstract][Full Text] [Related]
18. Insights into the chemistry and therapeutic potential of furanones: A versatile pharmacophore.
Husain A; Khan SA; Iram F; Iqbal MA; Asif M
Eur J Med Chem; 2019 Jun; 171():66-92. PubMed ID: 30909021
[TBL] [Abstract][Full Text] [Related]
19. An Appraisal on Synthetic and Medicinal Aspects of Fused Pyrimidines as Anti Neoplastic Agents.
Rani I; Kaur N; Goyal A; Sharma M
Anticancer Agents Med Chem; 2023; 23(5):525-561. PubMed ID: 35786337
[TBL] [Abstract][Full Text] [Related]
20. In search of uracil derivatives as bioactive agents. Uracils and fused uracils: Synthesis, biological activity and applications.
Pałasz A; Cież D
Eur J Med Chem; 2015 Jun; 97():582-611. PubMed ID: 25306174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
